ストックスクリーナーアプリを入手
0.3928
9.61%
-0.0418
Cdt Equity Inc (CDT) 最新ニュース
CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings - Bitget
CDT Equity files patents for tapinarof combination therapy - Investing.com
CDT Equity files patents for tapinarof combination therapy By Investing.com - Investing.com India
Psoriasis drug tapinarof gets 2 new patent filings as CDT targets licensing - Stock Titan
CDT Equity approves 1-for-25 reverse stock split effective Thursday - Investing.com India
Conduit to change name to CDT Equity - MSN
Cdt Equity Inc. announces reverse stock split - marketscreener.com
CDT Equity announces reverse stock split - MSN
CDT Equity Announces 1-for-25 Reverse Stock Split - TipRanks
Reverse split shrinks CDT Equity (NASDAQ: CDT) share count 25-to-1 - Stock Titan
CDT Equity Inc. Announces Reverse Stock Split - Bitget
CDT shrinks share count to about 4.7M in 1-for-25 reverse split - Stock Titan
Cdt identifies rare disease opportunities through Sarborg Signature Analysis, advancing out-licensing strategy - marketscreener.com
CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy - The Manila Times
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
If You Invested $1,000 in CDT Equity (CDT) - Stock Titan
CDT Equity Inc. 8-K Filing March 17, 2026: Company Details, Address, Trading Symbol, and Emerging Growth Status - Minichart
CDT Equity Shareholders Approve Major Capital Restructuring Measures - TipRanks
CDT Equity (NASDAQ: CDT) wins backing for large share issues and Cayman move - Stock Titan
CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth - Bitget
Cdt Equity stockholders approve all proposals at special meeting, positioning the company for next phase of growth - marketscreener.com
Cdt Equity Stockholders Approve All Proposals At Special Meeting, Positioning The Company For Next Phase Of Growth - TradingView
CDT Equity to map asset portfolio against rare disease database By Investing.com - Investing.com India
CDT Equity to map asset portfolio against rare disease database - Investing.com South Africa
CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence - The Manila Times
CDT Stock Price, Quote & Chart | CDT EQUITY INC (NASDAQ:CDT) - ChartMill
CDT Equity Expands Financing Through New Convertible Note - The Globe and Mail
Cdt Equity lowers floor price to $0.60 in purchase agreement amendment on March 3, 2026SEC filing - marketscreener.com
CDT Equity Lowers Floor Price To $0.60 In Purchase Agreement Amendment On March 3, 2026SEC Filing - TradingView
CDT Equity (CDT) lowers ELOC floor and issues $555,556 secured convertible note - Stock Titan
CDT Equity notes Sarborg patent filing for AI technology By Investing.com - Investing.com Canada
CDT Equity notes Sarborg patent filing for AI technology - Investing.com
CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent - Bitget
CDT Positions for Transformational Growth - Bitget
AI and drug assets: CDT puts $115M into Sarborg to fuel growth - Stock Titan
CDT Equity Inc. announced that it has received $0.555556 million in funding - marketscreener.com
CDT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Short Interest in CDT Equity Inc. (NASDAQ:CDT) Declines By 73.3% - Defense World
CDTTW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Conduit Pharmaceuticals Expands Stake Using Equity-Funded Acquisition Strategy - The Globe and Mail
CDT Equity to Acquire 20% of Sarborg in Stock, Pre-Funded Warrants and $8 Million Cash - TradingView
CDT Equity (NASDAQ: CDT) uses shares and warrants to acquire 20% of Sarborg - Stock Titan
CDT Equity Inc. Acknowledges Sarborg Limited's Expansion of AI Signature Agent Platform into Bacteria and Agrochemicals - Quiver Quantitative
CDT Equity Notes Sarborg Expansion into Bacteria and Agrochemicals - Bitget
CDT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
0.04%
0.06%
大文字化:
|
ボリューム (24 時間):